Trial updateRetina
A Study to Evaluate the Efficacy and Safety of VIS-101 in Participants With Neovascular Age-Related Macular Degeneration
Not yet recruiting. Phase 2. Registered enrolment: 244. Everest Medicines (China) Co.,Ltd.
Why it matters
Track this study through NCT07798375. No results are posted in this registry record.
The study at a glance
- Registry status
- Not yet recruiting
- Phase
- Phase 2
- Registered enrolment
- 244
- Results posted
- No
- Sponsor
- Everest Medicines (China) Co.,Ltd.
Keep in mind
Registry information describes the study; recruitment status alone does not establish efficacy or safety.